federal_register: E8-16396

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
E8-16396 Small Entity Compliance Guide: Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk; Availability Notice The Food and Drug Administration (FDA) is announcing theavailability of a small entity compliance guide (SECG) for a final rule published in the Federal Register of February 11, 2004 (69 FR 6788), entitled "Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk." This SECG is intended to set forth in plain language the requirements of the regulation and to help small businesses understand the regulation. 2008-07-17 2008 7 https://www.federalregister.gov/documents/2008/07/17/E8-16396/small-entity-compliance-guide-final-rule-declaring-dietary-supplements-containing-ephedrine https://www.govinfo.gov/content/pkg/FR-2008-07-17/pdf/E8-16396.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing theavailability of a small entity compliance guide (SECG) for a final rule published in the Federal Register of February 11, 2004 (69 FR 6788), entitled "Final Rule Declaring Dietary Supplements...  

Links from other tables